Belsomra (suvorexant) tablets 20 mg Each tablet contains 20 mg suvorexant. This package contains...
FDA Recall #D-0523-2021 — Class II — March 15, 2021
Product Description
Belsomra (suvorexant) tablets 20 mg Each tablet contains 20 mg suvorexant. This package contains 30 Tablets in 3 Blister Cards. Each Blister Card contains 10 Tablets. Rx only NDC 0006-0335-30 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. Whitehouse Station, NJ 08880, USA
Reason for Recall
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Recalling Firm
Cardinal Health Inc. — Dublin, OH
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
299 cartons
Distribution
FL, GA, SC
Code Information
1778598
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated
What Should You Do?
Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.